Abstract
Each year millions of pilgrims perform the annual Hajj from more than 180 countries around the world. This is one of the largest mass gathering events and may result in the occurrence and spread of infectious diseases. As such, there are mandatory vaccinations for the pilgrims such as meningococcal vaccines. The 2019 annual Hajj will take place during August 8–13, 2019. Thus, we review the recommended and mandated vaccinations for the 2019 Hajj and Umrah. The mandatory vaccines required to secure the visa include the quadrivalent meningococcal vaccine for all pilgrims, while yellow fever, and poliomyelitis vaccines are required for pilgrims coming from countries endemic or with disease activity. The recommended vaccines are influenza, pneumococcal, in addition to full compliance with basic vaccines for all pilgrims against diphtheria, tetanus, pertussis, polio, measles, and mumps. It is imperative to continue surveillance for the spread of antimicrobial resistance and occurrence of all infectious diseases causing outbreaks across the globe in the last year, like Zika virus, MDR-Typhoid, Nipah, Ebola, cholera, chikungunya and Middle East Respiratory Syndrome Coronavirus.
Article PDF
Avoid common mistakes on your manuscript.
References
Al-Tawfiq JA, Gautret P, Memish ZA. Expected immunizations and health protection for Hajj and Umrah 2018 —an overview. Travel Med Infect Dis 2017;19;2–7.
Gautret P, Benkouiten S, Al-Tawfiq JA, Memish ZA. Hajj-associated viral respiratory infections: a systematic review. Travel Med Infect Dis 2016;14;92–109.
Gautret P, Benkouiten S, Al-Tawfiq JA, Memish ZA. The spectrum of respiratory pathogens among returning Hajj pilgrims: myths and reality. Int J Infect Dis 2016;47;83–5.
Memish ZA, Al-Tawfiq JA, Al-Rabeeah AA. Hajj: preparations underway. Lancet Glob Health 2013;1;E331.
Memish ZA, Zumla A, Alhakeem RF, Assiri A, Turkestani A, Al Harby KD, et al. Hajj: infectious disease surveillance and control. Lancet 2014;383;2073–82.
Al-Tawfiq JA, Memish ZA. Mass gathering medicine: 2014 Hajj and Umra preparation as a leading example. Int J Infect Dis 2014;27;26–31.
Memish ZA, Al-Tawfiq JA. The Hajj in the time of an ebola outbreak in West Africa. Travel Med Infect Dis 2014;12;415–17.
Al-Tawfiq JA, Memish ZA. The Hajj: updated health hazards and current recommendations for 2012. Euro Surveill 2012;17;20295.
Al-Tawfiq JA, Memish ZA. Mass gatherings and infectious diseases: prevention, detection, and contr. Infect Dis Clin North Am 2012;26;725–37.
Lucidarme J, Scott KJ, Ure R, Smith A, Lindsay D, Stenmark B, et al. An international invasive meningococcal disease outbreak due to a novel and rapidly expanding serogroup W strain, Scotland and Sweden, July to August 2015. Eurosurveillance 2016;21;30395.
Wilder-Smith A, Goh KT, Barkham T, Paton NI. Hajj-associated outbreak strain of Neisseria meningitidis serogroup W135: estimates of the attack rate in a defined population and the risk of invasive disease developing in carriers. Clin Infect Dis 2003;36;679–83.
Aguilera J-F, Perrocheau A, Meffre C, Hahné S. Outbreak of sero-group W135 meningococcal disease after the Hajj pilgrimage, Europe, 2000. Emerg Infect Dis 2002;8;761–7.
Dull PM, Abdelwahab J, Sacchi CT, Becker M, Noble CA, Barnett GA, et al. Neisseria meningitidis Serogroup W-135 Carriage among US travelers to the 2001 Hajj. J Infect Dis 2005;191;33–9.
Al-Tawfiq JA, Clark TA, Memish ZA. Meningococcal disease: the organism, clinical presentation, and worldwide epidemiology. J Travel Med 2010;17;3–8.
Al-Gahtani YM, El Bushra HE, Al-Qarawi SM, Al-Zubaidi AA, Fontaine RE. Epidemiological investigation of an outbreak of meningococcal meningitis in Makkah (Mecca), Saudi Arabia, 1992. Epidemiol Infect 1995;115;399–409.
Moore PS, Reeves MW, Schwartz B, Gellin BG, Broome CV. Intercontinental spread of an epidemic group A Neisseria meningitidis strain. Lancet 1989;334;260–3.
Novelli VM, Lewis RG, Dawood ST. Epidemic group A meningococcal disease in Haj pilgrims. Lancet 1987;330;863.
Lingappa JR, Al-Rabeah AM, Hajjeh R, Mustafa T, Fatani A, Al-Bassam T, et al. Serogroup W-135 meningococcal disease during the Hajj, 2000. Emerg Infect Dis 2003;9;665–71.
Memish ZA, Assiri A, Almasri M, Alhakeem RF, Turkestani A, Al Rabeeah AA, et al. Prevalence of MERS-CoV nasal carriage and compliance with the Saudi health recommendations among pilgrims attending the 2013 Hajj. J Infect Dis 2014;210;1067–72.
Saudi Ministry of Health. Health Regulations - 2019/1440H-Hajj and Umrah Health Regulations n.d. https://www.moh.gov.sa/en/Hajj/HealthGuidelines/HealthGuidelinesDuringHajj/Pages/HealthRequirements.aspx (accessed June 22, 2019).
Parker AA, Staggs W, Dayan GH, Ortega-Sánchez IR, Rota PA, Lowe L, et al. Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States. N Engl J Med 2006;355;447–55.
Pfaff G, Lohr D, Santibanez S, Mankertz A, van Treeck U, Schonberger K, et al. Spotlight on measles 2010: measles outbreak among travellers returning from a mass gathering, Germany, September to October 2010. Euro Surveill 2010;15;pii: 19750.
Chen T-H, Kutty P, Lowe L, Hunt E, Blostein J, Espinoza R, et al. Measles outbreak associated with an international youth sporting event in the United States, 2007. Pediatr Infect Dis J 2010;29;794–800.
Memish ZA, Al-Tawfiq JA, Almasri M, Azhar EI, Yasir M, Al-Saeed MS, et al. Neisseria meningitidis nasopharyngeal carriage during the Hajj: a cohort study evaluating the need for ciprofloxacin prophylaxis. Vaccine 2017;35;2473–8.
Borrow R. Meningococcal disease and prevention at the Hajj. Travel Med Infect Dis 2009;7;219–25.
Memish Z, Al Hakeem R, Al Neel O, Danis K, Jasir A, Eibach D. Laboratory-confirmed invasive meningococcal disease: effect of the Hajj vaccination policy, Saudi Arabia, 1995 to 2011. Euro Surveill 2013;18;pii: 20581.
Memish ZA, Venkatesh S, Ahmed QA. Travel epidemiology: the Saudi perspective. Int J Antimicrob Agents 2003;21;96–101.
Mayer LW, Reeves MW, Al-Hamdan N, Sacchi CT, Taha M-K, Ajello GW, et al. Outbreak of W135 meningococcal disease in 2000; not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex. J Infect Dis 2002;185;1596–605.
Issack MI, Ragavoodoo C. Hajj-related Neisseria meningitidis serogroup w135 in Mauritius. Emerg Infect Dis 2002;8;332–4.
Folaranmi T, Rubin L, Martin SW, Patel M, MacNeil JR. Use of serogroup B meningococcal vaccines in persons aged ≥10 years at increased risk for serogroup B meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2015. MMWR Morb Mortal Wkly Rep 2015;64;608–12.
Memish ZA. Meningococcal disease and travel. Clin Infect Dis 2002;34;84–90.
Shibl A, Tufenkeji H, Khalil M, Memish Z. Consensus recommendation for meningococcal disease prevention for Hajj and Umra pilgrimage/travel medicine. East Mediterr Health J 2013;19;389–92.
Alborzi A, Oskoee S, Pourabbas B, Alborzi S, Astaneh B, Gooya MM, et al. Meningococcal carrier rate before and after hajj pilgrimage: effect of single dose ciprofloxacin on carriage. East Mediterr Health J 2008;14;277–82.
Wilder-Smith A, Barkham TMS, Chew SK, Paton NI. Absence of Neisseria meningitidis W-135 electrophoretic Type 37 during the Hajj, 2002. Emerg Infect Dis 2003;9;734–7.
Wilder-Smith A, Barkham TMS, Earnest A, Paton NI. Acquisition of W135 meningococcal carriage in Hajj pilgrims and transmission to household contacts: prospective study. BMJ 2002;325;365.
Memish ZA, Assiri A, Turkestani A, Yezli S, Al Masri M, Charrel R, et al. Mass gathering and globalization of respiratory pathogens during the 2013 Hajj. Clin Microbiol Infect 2015;21;571.e1–571.e8.
Mushtaq A, Mehmood S, Ur Rehman MA, Younas A, Ur Rehman MS, Malik MF, et al. Polio in Pakistan: social constraints and travel implications. Travel Med Infect Dis 2015;13;360–6.
Polio GLobal Eradication Initiative. Polio Today n.d. http://polioeradication.org/polio-today/polio-now/this-week/ (accessed June 23, 2019).
WHO EMRO. Polio eradication initiative n.d. http://www.emro.who.int/polio/countries/saudi-arabia.html (accessed June 23, 2019).
Wilder-Smith A, Leong W-Y, Lopez LF, Amaku M, Quam M, Khan K, et al. Potential for international spread of wild poliovirus via travelers. BMC Med 2015;13;133.
Elachola H, Chitale RA, Ebrahim SH, Wassilak SGF, Memish ZA. Polio priority countries and the 2018 Hajj: leveraging an opportunity. Travel Med Infect Dis 2018;25;3–5.
Ahmed QA, Arabi YM, Memish ZA. Health risks at the Hajj. Lancet 2006;367;1008–15.
WHO. International Health Regulations (IHR), 2005. https://www.who.int/ihr/finalversion9Nov07.pdf (last accessed July 25, 2019).
World Health Organization. New yellow fever vaccination requirements for travellers, 2016. http://www.who.int/ith/updates/20160727/en/ (accessed August 18, 2017).
World Health Organization. Countries with risk of yellow fever transmission and countries requiring yellow fever vaccination, 2016. http://www.who.int/ith/2016-ith-annex1.pdf?ua=1 (accessed August 20, 2017).
Rashid H, Shafi S, Booy R, El Bashir H, Ali K, Zambon MC, et al. Influenza and respiratory syncytial virus infections in British Hajj pilgrims. Emerg Health Threats J 2008;1;e2.
Kandeel A, Deming M, Elkreem EA, El-Refay S, Afifi S, Abukela M, et al. Pandemic (H1N1) 2009 and Hajj pilgrims who received predeparture vaccination, Egypt. Emerg Infect Dis 2011;17;1266–8.
Ziyaeyan M, Alborzi A, Jamalidoust M, Moeini M, Pouladfar GR, Pourabbas B, et al. Pandemic 2009 influenza A (H1N1) infection among 2009 Hajj Pilgrims from Southern Iran: a real-time RT-PCR-based study. Influenza Other Respir Viruses 2012;6;e80–e4.
Memish ZA, Assiri AM, Hussain R, Alomar I, Stephens G. Detection of respiratory viruses among pilgrims in Saudi Arabia during the time of a declared influenza A(H1N1) pandemic. J Travel Med 2012;19;15–21.
Refaey S, Amin MM, Roguski K, Azziz-Baumgartner E, Uyeki TM, Labib M, et al. Cross-sectional survey and surveillance for influenza viruses and MERS-CoV among Egyptian pilgrims returning from Hajj during 2012–2015. Influenza Other Respir Viruses 2016;11;57–60.
Ashshi A, Azhar E, Johargy A, Asghar A, Momenah A, Turkestani A, et al. Demographic distribution and transmission potential of influenza A and 2009 pandemic influenza A H1N1 in pilgrims. J Infect Dev Ctries 2014;8;1169–75.
Annan A, Owusu M, Marfo KS, Larbi R, Sarpong FN, Adu-Sarkodie Y, et al. High prevalence of common respiratory viruses and no evidence of Middle East respiratory syndrome corona-virus in Hajj pilgrims returning to Ghana, 2013. Trop Med Int Health 2015;20;807–12.
Benkouiten S, Charrel R, Belhouchat K, Drali T, Nougairede A, Salez N, et al. Respiratory viruses and bacteria among pilgrims during the 2013 Hajj. Emerg Infect Dis 2014;20;1821–7.
Gautret P, Charrel R, Benkouiten S, Belhouchat K, Nougairede A, Drali T, et al. Lack of MERS coronavirus but prevalence of influenza virus in French pilgrims after 2013 Hajj. Emerg Infect Dis 2014;20;728–30.
Rashid H, Shafi S, Haworth E, El Bashir H, Ali KA, Memish ZA, et al. Value of rapid testing for influenza among Hajj pilgrims. Travel Med Infect Dis 2007;5;310–3.
Rashid H, Shafi S, Haworth E, El Bashir H, Memish ZA, Sudhanva M, et al. Viral respiratory infections at the Hajj: comparison between UK and Saudi pilgrims. Clin Microbiol Infect 2008;14;569–74.
Alborzi A, Aelami MH, Ziyaeyan M, Jamalidoust M, Moeini M, Pourabbas B, et al. Viral etiology of acute respiratory infections among Iranian Hajj pilgrims, 2006. J Travel Med 2009;16;239–42.
Moattari A, Emami A, Moghadami M, Honarvar B. Influenza viral infections among the Iranian Hajj pilgrims returning to Shiraz, Fars province, Iran. Influenza Other Respir Viruses 2012;6;e77–e9.
Barasheed O, Almasri N, Badahdah A-M, Heron L, Taylor J, McPhee K, et al. Pilot randomised controlled trial to test effectiveness of facemasks in preventing influenza-like illness transmission among Australian Hajj pilgrims in 2011. Infect Disord Drug Targets 2014;14;110–6.
Barasheed O, Rashid H, Alfelali M, Tashani M, Azeem M, Bokhary H, et al. Viral respiratory infections among Hajj pilgrims in 2013. Virol Sin 2014;29;364–71.
Memish ZA, Almasri M, Turkestani A, Al-Shangiti AM, Yezli S. Etiology of severe community-acquired pneumonia during the 2013 Hajj—part of the MERS-CoV surveillance program. Int J Infect Dis 2014;25;186–90.
Aberle JH, Popow-Kraupp T, Kreidl P, Laferl H, Heinz FX, Aberle SW. Influenza A and B viruses but not MERS-CoV in Hajj pilgrims, Austria, 2014. Emerg Infect Dis 2015;21;726–7.
Alfelali M, Khandaker G, Booy R, Rashid H. Mismatching between circulating strains and vaccine strains of influenza: effect on Hajj pilgrims from both hemispheres. Hum Vaccin Immunother 2016;12;709–15.
Saudi Ministry of Health. Hajj 1438 Hijrah (2017) - Health Regulations, 2017. http://www.moh.gov.sa/en/Hajj/Pages/HealthRegulations.aspx (accessed August 18, 2017).
Alfelali M, Barasheed O, Tashani M, Azeem MI, El Bashir H, Memish ZA, et al. Changes in the prevalence of influenza-like illness and influenza vaccine uptake among Hajj pilgrims: a 10-year retrospective analysis of data. Vaccine 2015;33;2562–9.
Al-Tawfiq JA, Benkouiten S, Memish ZA. A systematic review of emerging respiratory viruses at the Hajj and possible coinfection with Streptococcus pneumoniae. Travel Med Infect Dis 2018;23;6–13.
Edouard S, Al-Tawfiq JA, Memish ZA, Yezli S, Gautret P. Impact of the Hajj on pneumococcal carriage and the effect of various pneumococcal vaccines. Vaccine 2018;36;7415–22.
Al-Tawfiq JA, Memish ZA. Prevention of pneumococcal infections during mass gathering. Hum Vaccin Immunother 2016;12;326–30.
Al-Tawfiq JA, Smallwood CAH, Arbuthnott KG, Malik MSK, Barbeschi M, Memish ZA. Emerging respiratory and novel coronavirus 2012 infections and mass gatherings. East Mediterr Health J 2013;19;S48–S54.
Atabani SF, Wilson S, Overton-Lewis C, Workman J, Kidd IM, Petersen E, et al. Active screening and surveillance in the United Kingdom for Middle East respiratory syndrome coronavirus in returning travellers and pilgrims from the Middle East: a prospective descriptive study for the period 2013–2015. Int J Infect Dis 2016;47;10–4.
ProMed. Novel coronavirus – Eastern Mediterranean (03); Saudi comment, 2013. http://promedmail.org/post/20130326.1603038 (accessed February 12, 2013).
Griffiths K, Charrel R, Lagier J-C, Nougairede A, Simon F, Parola P, et al. Infections in symptomatic travelers returning from the Arabian peninsula to France: a retrospective cross-sectional study. Travel Med Infect Dis 2016;14;414–6.
Gautret P, Charrel R, Belhouchat K, Drali T, Benkouiten S, Nougairede A, et al. Lack of nasal carriage of novel corona virus (HCoV-EMC) in French Hajj pilgrims returning from the Hajj 2012, despite a high rate of respiratory symptoms. Clin Microbiol Infect 2013;19;E315–E7.
Baharoon S, Al-Jahdali H, Al Hashmi J, Memish ZA, Ahmed QA. Severe sepsis and septic shock at the Hajj: etiologies and outcomes. Travel Med Infect Dis 2009;7;247–52.
Sridhar S, Brouqui P, Parola P, Gautret P. Imported cases of Middle East respiratory syndrome: an update. Travel Med Infect Dis 2015;13;106–9.
Al-Tawfiq JA, Zumla A, Memish ZA. Travel implications of emerging coronaviruses: SARS and MERS-CoV. Travel Med Infect Dis 2014;12;422–8.
Gautret P, Benkouiten S, Sridhar S, Al-Tawfiq JA, Memish ZA. Diarrhea at the Hajj and Umrah. Travel Med Infect Dis 2015;13;159–66.
McDonald R, Ruppert PS, Souto M, Johns DE, McKay K, Bessette N, et al. Notes from the field: measles outbreaks from imported cases in Orthodox Jewish communities — New York and New Jersey, 2018–2019. Am J Transplant 2019;19;2131–3.
Patel M, Lee AD, Redd SB, Clemmons NS, McNall RJ, Cohn AC, et al. Increase in measles cases — United States, January 1–April 26, 2019. Am J Transplant 2019;19;2127–30.
Carlson A, Riethman M, Gastañaduy P, Lee A, Leung J, Holshue M, et al. Notes from the field: Community outbreak of measles — Clark County, Washington, 2018–2019. Am J Transplant 2019;19;2134–5.
Mahase E. Measles cases rise 300% globally in first few months of 2019. BMJ 2019;365;l1810.
Gautret P, Steffen R. Communicable diseases as health risks at mass gatherings other than Hajj: what is the evidence? Int J Infect Dis 2016;47;46–52.
Al-Tawfiq JA, Gautret P, Benkouiten S, Memish ZA. Mass gatherings and the spread of respiratory infections. Lessons from the Hajj. Ann Am Thorac Soc 2016;13;759–65.
Elachola H, Assiri A, Turkestani AH, Sow SS, Petersen E, Al-Tawfiq JA, et al. Advancing the global health security agenda in light of the 2015 annual Hajj pilgrimage and other mass gatherings. Int J Infect Dis 2015;40;133–4.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
A. Al-Tawfiq, J., Memish, Z.A. The Hajj 2019 Vaccine Requirements and Possible New Challenges. J Epidemiol Glob Health 9, 147–152 (2019). https://doi.org/10.2991/jegh.k.190705.001
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2991/jegh.k.190705.001